Alphavirus replicon particles matched to protein antigens as immunological adjuvants
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 16, 2016
Grant Date -
Apr 14, 2011
app pub date -
Oct 18, 2010
filing date -
Sep 12, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The immune response to an antigen of interest, especially one in purified form, can be significantly enhanced by the simultaneous administration of an alphavirus replicon particle which expresses the same antigen. This allows for the use of significantly smaller quantities of the protein antigen than in conventional immunization strategies, and this new immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully